Funded Tech Companies
ImmunOs Therapeutics
Wondering who invested in ImmunOs Therapeutics? Pfizer Venture Investments, BioMed Ventures and Double Point Ventures invested in this innovative biopharmaceutical company.
Company Overview
Company Name
ImmunOs Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Wagistrasse 14
Schlieren, 8952
Switzerland
Schlieren, 8952
Switzerland
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
ImmunOs' approach is based on the identification of specific human leukocyte antigen (HLA) molecules that hyper-activate the immune system of patients with severe autoimmune disorders. The company has utilized this discovery to develop an HLA-based technology platform to generate a novel class of biologic therapeutics for the treatment of cancer and autoimmune disease.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/17/2024
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sean Smith
Chief Medical Officer
Christoph Renner
Chief Operating Officer
Jeffrey Abbey
Chief Scientific Officer
Osiris Belaunzaran
Vice President
Claudia Berger
VP - Bus. Development
Steve Coats
VP - Product Management
Lorenz Vogt
Company Investors
- Pfizer Venture Investments
- BioMed Ventures
- Double Point Ventures
- Mission BioCapital (Steve Tregay)
- GIMV (Andreas Jurgeit)
- Peak6
- Schroder Adveq
- Fiscus Ventures
- Lightspeed Venture Partners (Shelley Chu)
- GL Ventures
- Samsara BioCapital (Marcos Milla)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs